| Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation PA Jänne, GJ Riely, SM Gadgeel, RS Heist, SHI Ou, JM Pacheco, ... New England Journal of Medicine 387 (2), 120-131, 2022 | 404 | 2022 |
| Representation of minorities and women in oncology clinical trials: review of the past 14 years N Duma, J Vera Aguilera, J Paludo, CL Haddox, M Gonzalez Velez, ... Journal of oncology practice 14 (1), e1-e10, 2018 | 323 | 2018 |
| Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study RE Lewis, L Cahyame‐Zuniga, K Leventakos, G Chamilos, R Ben‐Ami, ... Mycoses 56 (6), 638-645, 2013 | 264 | 2013 |
| Fungal infections in leukemia patients: how do we prevent and treat them? K Leventakos, RE Lewis, DP Kontoyiannis Clinical Infectious Diseases 50 (3), 405-415, 2010 | 207 | 2010 |
| Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance R Ben-Ami, G Garcia-Effron, RE Lewis, S Gamarra, K Leventakos, ... Journal of Infectious Diseases 204 (4), 626-635, 2011 | 151 | 2011 |
| Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites R Ben-Ami, RE Lewis, K Leventakos, DP Kontoyiannis Blood, The Journal of the American Society of Hematology 114 (26), 5393-5399, 2009 | 129 | 2009 |
| Sex differences in tolerability to anti‐programmed cell death protein 1 therapy in patients with metastatic melanoma and non‐small cell lung cancer: are we all equal? N Duma, A Abdel‐Ghani, S Yadav, KP Hoversten, CT Reed, AN Sitek, ... The oncologist 24 (11), e1148-e1155, 2019 | 98 | 2019 |
| Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection R Ben-Ami, RE Lewis, J Tarrand, K Leventakos, DP Kontoyiannis Antimicrobial agents and chemotherapy 54 (1), 484-490, 2010 | 70 | 2010 |
| S768I mutation in EGFR in patients with lung cancer K Leventakos, BR Kipp, KM Rumilla, JL Winters, SY Eunhee, ... Journal of Thoracic Oncology 11 (10), 1798-1801, 2016 | 65 | 2016 |
| Using genomics to differentiate multiple primaries from metastatic lung cancer SJ Murphy, FR Harris, F Kosari, SBSP Terra, A Nasir, SH Johnson, ... Journal of Thoracic Oncology 14 (9), 1567-1582, 2019 | 61 | 2019 |
| Acute interstitial nephritis and checkpoint inhibitor therapy: single center experience of management and drug rechallenge S Manohar, R Ghamrawi, M Chengappa, BNB Goksu, L Kottschade, ... Kidney360 1 (1), 16-24, 2020 | 55 | 2020 |
| Advances in the treatment of non–small cell lung cancer: focus on nivolumab, pembrolizumab, and atezolizumab K Leventakos, AS Mansfield BioDrugs 30 (5), 397-405, 2016 | 53 | 2016 |
| Cutaneous model of invasive aspergillosis R Ben-Ami, RE Lewis, K Leventakos, JP Latgé, DP Kontoyiannis Antimicrobial agents and chemotherapy 54 (5), 1848-1854, 2010 | 42 | 2010 |
| Radiation and immunotherapy: emerging mechanisms of synergy WG Breen, K Leventakos, H Dong, KW Merrell Journal of thoracic disease 12 (11), 7011, 2020 | 40 | 2020 |
| Management of multifocal lung cancer: results of a survey K Leventakos, T Peikert, DE Midthun, JR Molina, S Blackmon, FC Nichols, ... Journal of Thoracic Oncology 12 (9), 1398-1402, 2017 | 39 | 2017 |
| Exploring the concordance of Aspergillus fumigatus pathogenicity in mice and Toll-deficient flies G Chamilos, EM Bignell, M Schrettl, RE Lewis, K Leventakos, GS May, ... Medical mycology 48 (3), 506-510, 2010 | 37 | 2010 |
| KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non–small cell lung cancer (NSCLC) harboring a KRASG12C mutation. AI Spira, GJ Riely, SM Gadgeel, RS Heist, SHI Ou, JM Pacheco, ... Journal of Clinical Oncology 40 (16_suppl), 9002-9002, 2022 | 34 | 2022 |
| Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract. 2018; 14 (1): e1–e10 N Duma, J Vera Aguilera, J Paludo, CL Haddox, M Gonzalez Velez, ... Duma et al. conduct a survey of 1012, 2017 | 33 | 2017 |
| Targeting HER 2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapy FR Harris, P Zhang, L Yang, X Hou, K Leventakos, SJ Weroha, ... Molecular Oncology 13 (2), 132-152, 2019 | 30 | 2019 |
| Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19 JC Pritchett, BJ Borah, AP Desai, Z Xie, AN Saliba, K Leventakos, ... JCO Oncology Practice 17 (9), e1293-e1302, 2021 | 26 | 2021 |
